Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 12, 2013 - Issue 3
Submit an article Journal homepage
240
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis

Warren WenPurdue Pharma L.P., One Stamford Forum, 7th Floor, Stamford, CT 06901, USA+1 203 588 7631; +1 203 588 6423; [email protected]
, PhD,
Shau Yu LynchPurdue Pharma L.P., Stamford, CT, USA
, PhD,
Catherine MuneraPurdue Pharma L.P., Stamford, CT, USA
, PhD,
Ruth SwantonRuth Swanton Consulting LLC, New Haven, CT, USA
, MPH,
Steven R RipaPurdue Pharma L.P., Stamford, CT, USA
, MD &
Howard MaibachUniversity of California, Department of Dermatology, San Francisco, CA, USA
, MD
Pages 309-319 | Published online: 19 Mar 2013

Bibliography

  • Ale I, Lachapelle J-M, Maibach HI. Skin tolerability associated with transdermal drug delivery systems: an overview. Adv Ther 2009;26(10):920-35
  • Proksch E, Brasch J. Abnormal epidermal barrier in the pathogenesis of contact dermatitis. Clin Dermatol 2012;30:335-44
  • Wohlrahb J, Kreft B, Tamke B. Skin tolerability of transdermal patches. Expert Opin Drug Deliv 2011;8(7):939-48
  • Hong I, Gabay M, Lodolce A. Safety concerns involving transdermal patches and magnetic resonance imaging (MRI). Hosp Pharm 2010;45(10):771-8
  • Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14:101-14
  • Ball AM, Smith KM. Optimizing transdermal drug therapy. Am J Health Syst Pharm 2008;65:1337-46
  • Butrans [package insert]. Purdue Pharma LP, Stamford, CT; 2011
  • Johnson RE, Fudala PJ, Payne R. Buprenorphine: considerations for pain management. J Pain Symptom Manage 2005;29(3):297-326
  • Climara Pro [package insert]. Bayer HealthCare Pharmaceuticals, Inc, Wayne NJ; 2007
  • Duragesic [package insert]. Janssen Pharmaceuticals, Inc, Titusville, NJ; 2011
  • Daytrana [package insert]. Noven Therapeutics, LLC, Miami, FL; 2010
  • Emsam [package insert]. Somerset Pharmaceuticals, Inc, Morgantown, WV; 2009
  • Estraderm [package insert]. Novartis Pharmaceuticals Corp, East Hanover, NJ; 2005
  • Exelon [package insert]. Novartis Pharmaceuticals Corp, East Hanover, NJ; 2010
  • Flector [package insert]. King Pharmaceuticals, Inc, Bristol, TN; 2011
  • Menostar [package insert]. Bayer HealthCare Pharmaceuticals, Inc, Wayne, NJ; 2007
  • Ortho Evra [package insert]. Ortho-McNeil-Janssen Pharmaceuticals, Inc, Raritan, NJ; 2011
  • Oxytrol [package insert]. Watson Pharma, Inc, Morristown, NJ; 2010
  • Sancuso [package insert]. ProStraken, Inc, Bedminster, NJ; 2008
  • Synera [package insert]. Zars Pharma, Inc, Salt Lake City, UT; 2010
  • Butrans. Physicians' desk reference 2011. 65th edition. PDR Network, LLC, Montvale, NJ; 2010. p. 2864-73
  • Butrans. Physicians' desk reference 2012. 66th edition. PDR Network LLC, Montvale, NJ; 2011. p. 2495-504
  • Duragesic. Physicians' desk reference 1992. 46th edition. Medical Economics Data, Montvale, NJ; 1992. p. 1133-6
  • Duragesic. Physicians' desk reference 2012. 66th edition. PDR Network LLC, Montvale, NJ; 2011. p. 1489-96
  • Duragesic. Physicians' desk reference 2004. 58th edition. Thompson PDR, Montvale, NJ; 2004. p. 1751-5
  • Catapres-TTS. [package insert]. Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT; 2012
  • Center for drug evaluation and research. Approval package for application number 19-813/S044. Food and Drug Administration Website. Available from http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/019813Orig1s044.pdf [Accessed February 19 2013]
  • Berti JJ, Lipsky JJ. Transcutaneous drug delivery: a practical review. Mayo Clin Proc 1995;70:581-6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.